KEMTROL SERUM CONTROL-ABNORMAL— 510(k) K920926

Name: FDA 510(k) clearance K920926
Creator: U.S. Food and Drug Administration
Published: 1992-05-07

Substantially Equivalent

Helena Laboratories

FDA 510(k) clearance K920926 for KEMTROL SERUM CONTROL-ABNORMAL, Substantially Equivalent on 1992-05-07. Applicant: Helena Laboratories. Device class: 1.

Clearance details

Applicant: Helena Laboratories
Product code: Code JJY
Device class: Class 1
Regulation: 21 CFR 862.1660
Advisory panel: Clinical Chemistry
Date received: 1992-02-28
Decision date: 1992-05-07
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Beaumont, TX, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code JJY

view all

K162530 — Multichem IA Plus2017-03-31
K163629 — Audit MicroControls Linearity FD Tumor Markers II2017-03-10
K163015 — Liquichek Tumor Marker Control-Level 1 +3 more2017-01-10
K153712 — VK-3 Verification Kit, VK-4 Verification Kit, VK-R5 Verification Kit, VK-R7 Verification Kit, VK-Crea Verification Kit2016-01-28
K150300 — Liquichek Cardiac Markers Plus Control LT2015-12-11

More clearances from Helena Laboratories

view all

K131479 — V8 SP NORMAL CONTROL, ABNORMAL CONTROL2013-10-07
K100103 — SPECIALTY ASSAYED CONTROL-22010-12-15
K061991 — PLATELETWORKS ARACHIDONIC ACID, MODEL PW-ACA2007-02-23
K061069 — SPIFE IFE-15 PENTAVALENT, MODEL 3456, SPIFE IFE-9 PENTAVALENT KIT, MODEL 3457, SPIFT IFE-6 PENTAVALENT KIT, MODEL 34582006-07-06
K061014 — ACTALYKE QC KIT, MODELS AQC-HP AND AQC-LP2006-05-10

Data sourced from openFDA. This site is unofficial and independent of the FDA.